This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cameco Shines as the Go-To Uranium Producer

Editor's note: Jim Cramer told viewers of his "Mad Money" TV show on Tuesday that Intuitive Surgical (ISRG) and Potash (POT) are two ugly ducklings set to become beautiful swans. Here's another stock with those same characteristics.

NEW YORK ( TheStreet) -- An "ugly duckling" stock can turn into a "swan" while few are noticing. What investors want to avoid are the "Black Swans," but I think we should embrace all swans as long as they don't lead to a "swan song."

One emerging swan is Cameco, (CCJ - Get Report), one of the crown jewels of the nuclear-energy realm.

Cameco wants to remain a dominant nuclear-energy company by increasing its annual uranium supply to meet growing worldwide demand.

Much of the world still depends on nuclear energy for electrical power, and the Environmental Protection Agency calls nuclear energy a "clean energy" and a reliable source.

According to the Department of Energy, nuclear power accounts for about 20% of electricity production in the U.S. and more than 100 nuclear generating units are in operation in the country. The EPA says uranium is an essential element to nuclear power.

Nuclear power is still a controversial subject and exceeds the scope of this article. My point is that uranium keeps the process going.

The Fukushima, Japan disaster that followed the major earthquake off the coast of Japan in March 2011 triggered worldwide fears about the safety of nuclear-power plants. That in turn caused the cancellation and closures of plants in Europe and the U.S., and led to a meltdown in uranium mining and producing stocks which can be seen in this five-year chart of Cameco. CCJ Chart CCJ data by YCharts

After Fukushima, shares of Cameco plunged from around $43 to below $17, although the trailing 12-month (TTM) revenue per share continued to rise. As you can see on the chart above, it has had two spikes higher, while Cameco shares have traded in a narrow range over the past 12 months.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CCJ $17.30 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%
TSLA $218.42 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs